Pfizer slashes revenue forecast on lower COVID sales, will cut costs
Published
Pfizer on Friday slashed its full-year revenue forecast by 13% and said it will cut $3.5 billion worth of jobs and expenses due to lower-than-expected sales of its COVID-19 vaccine and treatment. Pfizer earned record revenue in 2021 and 2022, topping $100 billion last year, after developing its…
#pfizer #comirnaty #albertboura #medicare #medicaid